ArticleIranian journal of pharmaceutical research : IJPR2019

Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker.

Amirali Delnavaz Shahr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.